Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Research Scholarships - Master's program

University of Ottawa

$27,000.00

N-of-1 and N-of-few trials in rare pediatric diseases: current methods and proposal for future design

EF 2025-26

Résumé
Ultra-rare diseases individually affect small numbers of children, often only a few across Canada. This makes it difficult to evaluate new treatments using traditional randomized controlled trials. At the same time, advances in technology are leading to improved therapies. These new treatments are promising but the evidence supporting their use often remains weak. Families and clinicians are frequently left without clear information about whether a treatment is effective, safe, or likely to help. Individualized study designs known as N-of-1 and N-of-few trials, offer a possible solution by allowing researchers to evaluate treatments in a single child or a very small group. Although these designs are increasingly used in rare disease research, we do not yet understand how well they address common sources of bias or whether the methods used are suitable. This project will review and critically assess N-of-1 and N-of-few trials involving children with rare diseases published or proposed since 2014. We will examine how these studies were designed, how treatment effects were measured and whether the methods used were strong enough to produce valid results. We will also identify strategies that researchers used to improve feasibility or reduce bias when only a few children could be enrolled. Using these findings and working with clinicians and patient partners in our research network, we will develop an example protocol for a future ultra-rare disease trial. This protocol will show how an N-of-few trial can be designed to be ethical, feasible, and scientifically rigorous. The goal of this project is to improve the quality of research in ultra-rare pediatric diseases so that children and families can benefit from more trustworthy evidence when new therapies become available.
Programme
Master's Award: Canada Graduate Research Scholarships - Master's program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
572898
Name
Yassin Maryam
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
N-of-1 and N-of-few trials in rare pediatric diseases: current methods and proposal for future design
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Clinical Trials; N-Of-1 Studies; N-Of-Few Studies; Pediatrics; Rare Diseases; Scoping Review; Trial Protocol
Abstract
Ultra-rare diseases individually affect small numbers of children, often only a few across Canada. This makes it difficult to evaluate new treatments using traditional randomized controlled trials. At the same time, advances in technology are leading to improved therapies. These new treatments are promising but the evidence supporting their use often remains weak. Families and clinicians are frequently left without clear information about whether a treatment is effective, safe, or likely to help. Individualized study designs known as N-of-1 and N-of-few trials, offer a possible solution by allowing researchers to evaluate treatments in a single child or a very small group. Although these designs are increasingly used in rare disease research, we do not yet understand how well they address common sources of bias or whether the methods used are suitable. This project will review and critically assess N-of-1 and N-of-few trials involving children with rare diseases published or proposed since 2014. We will examine how these studies were designed, how treatment effects were measured and whether the methods used were strong enough to produce valid results. We will also identify strategies that researchers used to improve feasibility or reduce bias when only a few children could be enrolled. Using these findings and working with clinicians and patient partners in our research network, we will develop an example protocol for a future ultra-rare disease trial. This protocol will show how an N-of-few trial can be designed to be ethical, feasible, and scientifically rigorous. The goal of this project is to improve the quality of research in ultra-rare pediatric diseases so that children and families can benefit from more trustworthy evidence when new therapies become available.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Yassin, Maryam
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~